1. Home
  2. RAPT vs TOYO Comparison

RAPT vs TOYO Comparison

Compare RAPT & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • TOYO
  • Stock Information
  • Founded
  • RAPT 2015
  • TOYO 2022
  • Country
  • RAPT United States
  • TOYO Japan
  • Employees
  • RAPT N/A
  • TOYO N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • TOYO
  • Sector
  • RAPT Health Care
  • TOYO
  • Exchange
  • RAPT Nasdaq
  • TOYO NYSE
  • Market Cap
  • RAPT 117.5M
  • TOYO 131.2M
  • IPO Year
  • RAPT 2019
  • TOYO N/A
  • Fundamental
  • Price
  • RAPT $0.75
  • TOYO $3.02
  • Analyst Decision
  • RAPT Hold
  • TOYO
  • Analyst Count
  • RAPT 7
  • TOYO 0
  • Target Price
  • RAPT $5.00
  • TOYO N/A
  • AVG Volume (30 Days)
  • RAPT 829.4K
  • TOYO 10.1K
  • Earning Date
  • RAPT 05-08-2025
  • TOYO 04-28-2025
  • Dividend Yield
  • RAPT N/A
  • TOYO N/A
  • EPS Growth
  • RAPT N/A
  • TOYO N/A
  • EPS
  • RAPT N/A
  • TOYO 0.76
  • Revenue
  • RAPT N/A
  • TOYO $200,455,385.00
  • Revenue This Year
  • RAPT N/A
  • TOYO N/A
  • Revenue Next Year
  • RAPT N/A
  • TOYO N/A
  • P/E Ratio
  • RAPT N/A
  • TOYO $3.95
  • Revenue Growth
  • RAPT N/A
  • TOYO N/A
  • 52 Week Low
  • RAPT $0.75
  • TOYO $1.36
  • 52 Week High
  • RAPT $8.58
  • TOYO $15.61
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 33.73
  • TOYO N/A
  • Support Level
  • RAPT $0.75
  • TOYO N/A
  • Resistance Level
  • RAPT $0.85
  • TOYO N/A
  • Average True Range (ATR)
  • RAPT 0.08
  • TOYO 0.00
  • MACD
  • RAPT -0.00
  • TOYO 0.00
  • Stochastic Oscillator
  • RAPT 0.97
  • TOYO 0.00

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.

Share on Social Networks: